- Home
- STRW vs LFCR Comparison
STRW vs LFCR Comparison
Compare STRW & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$13.85
N/A
Current Price
$4.45
Company Overview
Basic Information| Metric | STRW | LFCR |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.0M | 190.9M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | STRW | LFCR |
|---|---|---|
| Price | $13.85 | $4.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $13.88 | $6.00 |
| AVG Volume (30 Days) | 45.2K | ★ 125.1K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.17% | N/A |
| EPS Growth | ★ 5.26 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | $154,999,000.00 | ★ $557,559,000.00 |
| Revenue This Year | $8.52 | N/A |
| Revenue Next Year | $3.95 | $5.04 |
| P/E Ratio | $42.00 | ★ N/A |
| Revenue Growth | ★ 32.41 | 6.36 |
| 52 Week Low | $11.11 | $3.63 |
| 52 Week High | $14.75 | $8.98 |
Technical Indicators
Market Signals| Indicator | STRW | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 52.42 | 44.69 |
| Support Level | $12.59 | $4.20 |
| Resistance Level | $14.75 | $5.21 |
| Average True Range (ATR) | 0.41 | 0.27 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 57.04 | 35.93 |
Price Performance
Historical Comparison STRW
LFCR
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.